Communicating quantitative risks and benefits in promotional prescription drug labeling or print advertising
Article first published online: 26 FEB 2013
Copyright © 2013 John Wiley & Sons, Ltd.
Pharmacoepidemiology and Drug Safety
Volume 22, Issue 5, pages 447–458, May 2013
How to Cite
West, S. L., Squiers, L. B., McCormack, L., Southwell, B. G., Brouwer, E. S., Ashok, M., Lux, L., Boudewyns, V., O'Donoghue, A. and Sullivan, H. W. (2013), Communicating quantitative risks and benefits in promotional prescription drug labeling or print advertising. Pharmacoepidem. Drug Safe., 22: 447–458. doi: 10.1002/pds.3416
- Issue published online: 3 MAY 2013
- Article first published online: 26 FEB 2013
- Manuscript Accepted: 10 JAN 2013
- Manuscript Revised: 4 JAN 2013
- Manuscript Received: 30 SEP 2012
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!